Letter to the Editor: Living Donor Liver Transplantation or Deceased Donor Liver Transplantation in High Model for End-Stage Liver Disease Score-Which Is Better?

We read with interest the study by Wong et al. (1) We congratulate the authors for the commendable work. We would like to share our concerns regarding the study. There were a greater number of patients with hepatorenal syndrome (HRS) in the deceased donor liver transplantation (DDLT) group than living donor liver transplantation (LDLT) group. (1) Presence of HRS, even in a low model for end-stage liver disease (MELD) patient, increases the risk of waitlist mortality which may be one of the reasons for higher waitlist mortality in the DDLT group.